Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract. - Wikidata - awgldk - TriplyDB

Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.

Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.

http://www.wikidata.org/entity/Q39022486

about

Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface Advances in HIV microbicide development The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors Enhancing Interferon Regulatory Factor 7 Mediated Antiviral Responses and Decreasing Nuclear Factor Kappa B Expression Limit HIV-1 Replication in Cervical Tissues New approaches to making the microenvironment of the female reproductive tract hostile to HIV.Tenofovir Inhibits Wound Healing of Epithelial Cells and Fibroblasts from the Upper and Lower Human Female Reproductive Tract.Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank.Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies Glucocorticoid-induced reversal of interleukin-1β-stimulated inflammatory gene expression in human oviductal cells.Estradiol regulation of constitutive and keratinocyte growth factor-induced CCL20 and CXCL1 secretion by mouse uterine epithelial cells.HIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors.Raised trappin2/elafin protein in cervico-vaginal fluid is a potential predictor of cervical shortening and spontaneous preterm birth.Trappin-2/elafin modulate innate immune responses of human endometrial epithelial cells to PolyI:C Uterine epithelial cells specifically induce interferon-stimulated genes in response to polyinosinic-polycytidylic acid independently of estradiol.Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells.Immune responses to HIV in the female reproductive tract, immunologic parallels with the gastrointestinal tract, and research implications Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV Epithelial cell secretions from the human female reproductive tract inhibit sexually transmitted pathogens and Candida albicans but not Lactobacillus.Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection.Effect of tenofovir on nucleotidases and cytokines in HIV-1 target cells.Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals.Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.High Expression of Antiviral Proteins in Mucosa from Individuals Exhibiting Resistance to Human Immunodeficiency Virus The Microbiological Context of HIV Resistance: Vaginal Microbiota and Mucosal Inflammation at the Viral Point of Entry Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells HIV-Enhancing Factors Are Secreted by Reproductive Epithelia upon Inoculation with Bacterial Vaginosis-Associated Bacteria.In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.Pathogen recognition in the human female reproductive tract: expression of intracellular cytosolic sensors NOD1, NOD2, RIG-1, and MDA5 and response to HIV-1 and Neisseria gonorrhea.

P2860

Q21245044-92003371-6F7B-49D8-A671-D623519A180A Q26852858-7E21908A-0DB3-4FA9-937D-06A7AEFF7F0E Q27000032-543C7723-59FD-4466-9DED-788BA2E8281D Q28087327-C8469F61-55D0-4468-B609-36F264469B5B Q28388054-32DAA996-E032-4DCF-BBDF-3950F31EDBCC Q28545896-BB3F5623-82B6-403B-8140-E22DAAE1C60F Q30398454-0DC8AD01-A9D6-4A82-A0A6-24DF35E35935 Q30843736-F1BA72DB-C515-4036-825A-082696438C1B Q33456377-C448D844-7CF3-4EB8-8123-95054870F5FC Q33627673-A73FD054-6335-4A28-9DD6-09A07804D795 Q33645478-0432CA90-519B-43E3-A54A-6F5D4BB6D5DB Q33748030-3DDB51A0-3722-4D4B-AADB-6337D2E2F1AD Q33753950-D9593374-0F71-407C-A24C-6E2DB51A46CA Q33955266-7145E4F4-885C-465D-8002-1999FE4E121C Q33974985-6EAC4BD6-3F05-49D5-898D-AC41C093D138 Q34251265-C822536D-DB57-400D-A42C-75CB8355DFE0 Q34256586-6B3C1D58-C61C-4B01-BEFF-62AB00F9D775 Q34295695-45D5C61F-FB89-4D21-9CE2-D56FDC700954 Q34339797-4DC67F92-FE75-4ED4-9DFC-A605EF78F0E1 Q34467932-231BFBF7-3DDB-493A-BB29-AA6D87642451 Q34541093-020B401E-40F7-4ED6-938D-C67D00D1EE87 Q34712244-3917A2DD-BBA7-42D4-9725-B32C1EDE5DDB Q34767047-B4DD7543-EB5C-420B-9776-5C4435475EE5 Q34982574-38C80B10-674D-493D-8DF3-F926C4278864 Q35030053-136ABD67-0607-494E-8E04-A8B996E08A47 Q35036745-9E7C8D67-9BFA-469F-8192-47B545A3451C Q35078336-2416B633-59DA-4019-BE20-AC012F67B883 Q35092851-7B0AC641-E201-4BD7-AF43-67BF3286AD77 Q35153994-0BE9D686-D243-4C13-A52C-11CA1D086BD3 Q35168267-88D77A96-B21A-4AFB-82E2-161BA0920BF9 Q35548029-D11A0099-D8F4-4C60-9F62-71BD0B0576E1 Q35668959-1B660B28-B638-426D-AC5A-57D940B9717E Q35852782-7A5FEBB3-1520-4436-A01C-3EFCFC41B817 Q35868058-423E0FBD-1BD0-4A84-BD88-72619E32E8C0 Q35892272-40D169BE-6A7E-4E37-8470-F6AA9ACDA557 Q36059879-B731B5BB-AD2F-42F3-B92E-E7390A0AB773 Q36104532-9F7913E5-7388-430C-B51F-C47BB802A3BD Q36294698-E0416877-2062-4AF6-88F3-2A7E66BD09F0 Q36358905-1C6874C3-8C71-430E-A17D-11447A5ADC86 Q36456996-8601E8E8-297E-41E5-B952-A5B1A6DFBBA9

P2860

Trappin-2/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract.

http://www.wikidata.org/entity/Q39022486

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Trappin-2/Elafin: a novel inna ...... man female reproductive tract.

@en

Trappin-2/Elafin: a novel inna ...... man female reproductive tract.

@nl

type

label

Trappin-2/Elafin: a novel inna ...... man female reproductive tract.

@en

Trappin-2/Elafin: a novel inna ...... man female reproductive tract.

@nl

prefLabel

Trappin-2/Elafin: a novel inna ...... man female reproductive tract.

@en

Trappin-2/Elafin: a novel inna ...... man female reproductive tract.

@nl

P1433

Q39022486-9870DBDD-3D4A-43C7-BB96-0DA0F5EDE946

P1476

Q39022486-378041FC-F7F3-4E76-8058-7FBD9569A7D1

P2093

Q39022486-0CEB28CF-FC3E-4511-A62E-3DD4B23679FF

Q39022486-6687A35C-E764-470B-A427-6C87EF6A986D

Q39022486-6C0E9BDC-4523-4CE5-8639-69E323E1B6C5

Q39022486-776CF52E-2A5C-401B-B9AF-663A3E029EB2

Q39022486-B4DD865E-6445-4486-A810-702314CFBF53

P2860

Q39022486-00068D3D-FD21-4891-959C-7DA4A1F1ACA0

Q39022486-07A359C9-C5CA-4BA6-9B64-420424EC698A

Q39022486-08D9FF8E-8F71-46B7-B4F0-83E66DF2A8DF

Q39022486-0A9B37CC-C0C4-4627-BF94-9D12F4A99BFB

Q39022486-19E8F357-BE55-4ABF-AC44-7AA39078CCBE

Q39022486-1B094EDA-5E14-430B-B0D6-594E98703613

Q39022486-24D09632-F092-49E2-AACA-CF0E0F30D0E5

Q39022486-2C7EA554-B5AC-465D-8A92-7C40B7F5E7E5

Q39022486-30AF6A87-AD0E-4450-AF74-94FAF6E22747

Q39022486-37C46381-D897-4BB5-8220-85DA76BA2E85

P304

Q39022486-68BB2F0B-3E22-4D63-825F-F2F32EC1E476

P31

Q39022486-434A5FC3-3574-4A37-91F1-E9064C771CF5

P356

Q39022486-1653964D-241D-4928-A48E-E13F755609BF

P433

Q39022486-69C04EB8-FAFD-4830-B427-BB13EA16AE00

P478

Q39022486-7CD2A52C-2882-4BDF-BDC6-21012AE4330E

P50

Q39022486-6D314132-AC70-4E68-971D-4DE504835D01

P577

Q39022486-4A18CDB2-7A84-4E7E-9C7E-DBD2AFF470C3

P5875

Q39022486-B9C19832-8B4A-46EF-B3E8-EBBD25C88B58

P698

Q39022486-8B588174-ADBA-4D1C-85E0-4694758B677F

P932

Q39022486-8AF5EAC2-6113-4197-A568-ACE62B0A16FD

P356

J.1365-2567.2009.03165.X

P1433

P1476

Trappin-2/Elafin: a novel inna ...... man female reproductive tract.

@en

P2093

Charles R Wira

http://www.w3.org/2001/XMLSchema#string

John V Fahey

http://www.w3.org/2001/XMLSchema#string

Mimi Ghosh

http://www.w3.org/2001/XMLSchema#string

Susan Cu-Uvin

http://www.w3.org/2001/XMLSchema#string

Zheng Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin

Stromal cell-derived factors 1alpha and 1beta, inflammatory protein-10 and interferon-inducible T cell chemo-attractant are novel substrates of dipeptidyl peptidase 8

The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core

Constitutive and inducible expression of SKALP/elafin provides anti-elastase defense in human epithelia

Innate immune defences in the human endometrium

Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections

Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.

Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status.

P304

207-219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2567.2009.03165.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26890538

http://www.w3.org/2001/XMLSchema#string

P698

19824918

http://www.w3.org/2001/XMLSchema#string

P932

2814463

http://www.w3.org/2001/XMLSchema#string